{"_buckets": {"deposit": "6700560c-6388-401d-91dc-4a297f0a8b23"}, "_deposit": {"id": "11484", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "11484"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00011484", "sets": ["456", "997"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Trastuzumab (Herceptin^[○!R]) Therapy in Breast Cancer(Molecular Targeted Therapy for Cancer)"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2007-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "11", "bibliographicPageEnd": "625", "bibliographicPageStart": "622", "bibliographicVolumeNumber": "121", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The HER2 gene, which encodes the growth factor receptor HER2, is amplified and HER2 is overexpressed in 25 to 30 percent of breast cancers, increasing the aggressiveness of the tumor. Trastuzumab (Herceptin^[○!R]), a recombinant monoclonal antibody against HER2 has been becoming a key drug for HER2-overexpressed breast cancer, moreover to be used in ajuvant and neoadjuvant settings.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "77988", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Koyama, Yu"}]}, {"nameIdentifiers": [{"nameIdentifier": "77989", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Hatakeyama, Katsuyoshi"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_relation_31": {"attribute_name": "異版である", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://ci.nii.ac.jp/naid/110007146177", "subitem_relation_type_select": "URI"}}]}, "item_7_rights_15": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "本文データは学協会の許諾に基づきCiNiiから複製したものである"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "小山, 諭"}], "nameIdentifiers": [{"nameIdentifier": "77986", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "畠山, 勝義"}], "nameIdentifiers": [{"nameIdentifier": "77987", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-07"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "110007146177.pdf", "filesize": [{"value": "307.3 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 307300.0, "url": {"label": "110007146177.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/11484/files/110007146177.pdf"}, "version_id": "bbcc3453-bb2e-4282-a963-bdf80e9cb47e"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Trastuzumab (Herceptin^[○!R])", "subitem_subject_scheme": "Other"}, {"subitem_subject": "breast cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "adjuvant therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "neoadjuvant therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "HER2/neu", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "5 乳癌におけるトラスツヅマブ(ハーセプチン^[○!R])療法(シンポジウム がんの分子標的治療, 第628回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "5 乳癌におけるトラスツヅマブ(ハーセプチン^[○!R])療法(シンポジウム がんの分子標的治療, 第628回新潟医学会)"}, {"subitem_title": "5 乳癌におけるトラスツヅマブ(ハーセプチン^[○!R])療法(シンポジウム がんの分子標的治療, 第628回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "997"], "permalink_uri": "http://hdl.handle.net/10191/32855", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-08-07"}, "publish_date": "2015-08-07", "publish_status": "0", "recid": "11484", "relation": {}, "relation_version_is_last": true, "title": ["5 乳癌におけるトラスツヅマブ(ハーセプチン^[○!R])療法(シンポジウム がんの分子標的治療, 第628回新潟医学会)"], "weko_shared_id": null}